Aytu Biopharma Inc (AYTU)

Aytu Biopharma Inc Azioni (AYTU) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	29.77%16.11	12.41	15.17	13.89	15.14
Cost Of Revenue	18.39%5.70	4.81	5.54	4.70	4.88
Gross Profit	36.98%10.41	7.60	9.62	9.19	10.25
	4.09%11.19	11.66	11.59	10.69	17.88
Research and Development	-	-	-	-	0.22
Operating Income/Loss	80.88%-0.78	-4.06	-1.97	-1.50	-7.62
Income/Loss From Continuing Operations Before Tax	99.93%-0.00	-5.61	-10.58	1.97	-19.44
Income Tax Expense/Benefit	10.00%0.01	0.01	-	-	0.44
Income/Loss From Continuing Operations After Tax	99.73%-0.02	-5.62	-10.58	1.97	-19.88
Income/Loss From Discontinued Operations, Net Of Tax	-	-	-	-	0.06
	99.73%-0.02	-5.62	-10.58	1.97	-19.82
Attributable To Parent	99.73%-0.02	-5.62	-10.58	1.97	-19.82